Fujian Wanchen Biotechnology Group Co., Ltd. (SHE:300972)
China
· Delayed Price · Currency is CNY 165.38
+18.90 (12.90%)
Last updated: Apr 30, 2025
SHE:300972 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 37,876 | 31,885 | 9,234 | 549.11 | 434.7 | 449.89 | Upgrade
|
| Other Revenue | 443.67 | 443.67 | 60.17 | 0.15 | - | 0.1 | Upgrade
|
| Revenue | 38,319 | 32,329 | 9,294 | 549.26 | 434.7 | 449.98 | Upgrade
|
| Revenue Growth (YoY) | 186.77% | 247.86% | 1592.03% | 26.35% | -3.40% | -0.21% | Upgrade
|
| Cost of Revenue | 34,139 | 28,869 | 8,440 | 462.11 | 391.7 | 325.24 | Upgrade
|
| Gross Profit | 4,180 | 3,460 | 854.2 | 87.15 | 43.01 | 124.74 | Upgrade
|
| Selling, General & Admin | 2,698 | 2,405 | 875.54 | 51.39 | 25.21 | 22.04 | Upgrade
|
| Research & Development | 4.21 | 4.04 | 3.31 | 1.95 | 1.99 | 0.43 | Upgrade
|
| Other Operating Expenses | 92.66 | 63.42 | 20.97 | 3.29 | 3.09 | 2.85 | Upgrade
|
| Operating Expenses | 2,790 | 2,474 | 900.52 | 57.41 | 30.32 | 25.33 | Upgrade
|
| Operating Income | 1,390 | 986.02 | -46.32 | 29.74 | 12.68 | 99.41 | Upgrade
|
| Interest Expense | -56.32 | -50.85 | -28.75 | -4.2 | -5.18 | -7.55 | Upgrade
|
| Interest & Investment Income | 18.51 | 14.11 | 1.68 | 3.18 | 3.01 | 0.33 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | -0 | - | -0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.14 | -5.88 | -7.22 | -0.2 | -0.07 | 0.03 | Upgrade
|
| EBT Excluding Unusual Items | 1,349 | 943.4 | -80.6 | 28.52 | 10.44 | 92.21 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.2 | 0.03 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -5.86 | -8.3 | -3.26 | -1.66 | -0.49 | -0.1 | Upgrade
|
| Asset Writedown | -8.45 | -11.05 | -4.04 | -0.31 | -0.1 | -0.05 | Upgrade
|
| Other Unusual Items | 108.38 | 108.38 | 3.19 | 14.83 | 19.18 | 4.07 | Upgrade
|
| Pretax Income | 1,443 | 1,032 | -84.72 | 41.58 | 29.06 | 96.13 | Upgrade
|
| Income Tax Expense | 520.76 | 429.18 | 61.3 | 0.04 | 5.61 | - | Upgrade
|
| Earnings From Continuing Operations | 922.16 | 603.26 | -146.02 | 41.54 | 23.45 | 96.13 | Upgrade
|
| Minority Interest in Earnings | -420.02 | -309.74 | 63.1 | 6.2 | - | - | Upgrade
|
| Net Income | 502.14 | 293.52 | -82.93 | 47.74 | 23.45 | 96.13 | Upgrade
|
| Net Income to Common | 502.14 | 293.52 | -82.93 | 47.74 | 23.45 | 96.13 | Upgrade
|
| Net Income Growth | - | - | - | 103.57% | -75.61% | 4.28% | Upgrade
|
| Shares Outstanding (Basic) | 176 | 171 | 154 | 153 | 141 | 114 | Upgrade
|
| Shares Outstanding (Diluted) | 194 | 187 | 154 | 155 | 141 | 114 | Upgrade
|
| Shares Change (YoY) | 24.89% | 21.78% | -0.92% | 10.29% | 22.92% | -0.69% | Upgrade
|
| EPS (Basic) | 2.85 | 1.71 | -0.54 | 0.31 | 0.17 | 0.84 | Upgrade
|
| EPS (Diluted) | 2.59 | 1.57 | -0.54 | 0.31 | 0.17 | 0.84 | Upgrade
|
| EPS Growth | - | - | - | 84.58% | -80.16% | 5.00% | Upgrade
|
| Free Cash Flow | 1,176 | 731.69 | 804.17 | -245.96 | 57.25 | 100.14 | Upgrade
|
| Free Cash Flow Per Share | 6.05 | 3.91 | 5.23 | -1.58 | 0.41 | 0.88 | Upgrade
|
| Dividend Per Share | 0.600 | 0.600 | - | - | 0.220 | - | Upgrade
|
| Gross Margin | 10.91% | 10.70% | 9.19% | 15.87% | 9.89% | 27.72% | Upgrade
|
| Operating Margin | 3.63% | 3.05% | -0.50% | 5.42% | 2.92% | 22.09% | Upgrade
|
| Profit Margin | 1.31% | 0.91% | -0.89% | 8.69% | 5.39% | 21.36% | Upgrade
|
| Free Cash Flow Margin | 3.07% | 2.26% | 8.65% | -44.78% | 13.17% | 22.25% | Upgrade
|
| EBITDA | 1,498 | 1,090 | 42.08 | 89.94 | 73.92 | 159.01 | Upgrade
|
| EBITDA Margin | 3.91% | 3.37% | 0.45% | 16.38% | 17.00% | 35.34% | Upgrade
|
| D&A For EBITDA | 107.92 | 104.02 | 88.4 | 60.2 | 61.24 | 59.61 | Upgrade
|
| EBIT | 1,390 | 986.02 | -46.32 | 29.74 | 12.68 | 99.41 | Upgrade
|
| EBIT Margin | 3.63% | 3.05% | -0.50% | 5.42% | 2.92% | 22.09% | Upgrade
|
| Effective Tax Rate | 36.09% | 41.57% | - | 0.10% | 19.31% | - | Upgrade
|
| Revenue as Reported | 38,319 | 32,329 | 9,294 | 549.26 | 434.7 | 449.98 | Upgrade
|
| Advertising Expenses | - | 513.2 | 50.2 | 0.42 | 0.07 | 0.34 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.